Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampin-resistant Tuberculosis”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Looking for participantsNCT05534750
What this trial is testing

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Who this might be right for
TuberculosisMultidrug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 60
Large-scale testing (Phase 3)Study completedNCT00933790
What this trial is testing

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Who this might be right for
HIV InfectionPulmonary TB
Tuberculosis Research Centre, India 331
Not applicableLooking for participantsNCT05671718
What this trial is testing

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Who this might be right for
Drug Resistant Tuberculosis
Johns Hopkins University 2,944
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Large-scale testing (Phase 3)Looking for participantsNCT05081401
What this trial is testing

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Who this might be right for
Multidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital 1,050
Not applicableActive Not RecruitingNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Post-approval studies (Phase 4)Looking for participantsNCT06476210
What this trial is testing

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Who this might be right for
Pulmonary Tuberculosis
Beijing Chest Hospital 45
Post-approval studies (Phase 4)Looking for participantsNCT05381194
What this trial is testing

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Who this might be right for
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT07170800
What this trial is testing

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Who this might be right for
TuberculosisMultidrug Resistant Pulmonary TuberculosisRifampicin-resistant Tuberculosis
WestVac Biopharma Co., Ltd. 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06081361
What this trial is testing

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Who this might be right for
Pulmonary TuberculosisRifampicin-resistant Tuberculosis
Beijing Chest Hospital 186
Not applicableUnknownNCT04545788
What this trial is testing

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Who this might be right for
Tuberculosis
Beijing Chest Hospital 200
Not applicableLooking for participantsNCT05073926
What this trial is testing

Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

Who this might be right for
Latent TuberculosisStaphylococcus Aureus
Region Skane 100
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT03072576
What this trial is testing

Accuracy and Feasibility of Xpert Ultra

Who this might be right for
Tuberculosis, Pulmonary
Foundation for Innovative New Diagnostics, Switzerland 1,400
Large-scale testing (Phase 3)Active Not RecruitingNCT06649721
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Who this might be right for
Drug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis
Huashan Hospital 120
Not applicableLooking for participantsNCT06590428
What this trial is testing

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Who this might be right for
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Albert Einstein College of Medicine 280
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Load More Results